PRMB CEO Eric Foss Leads $2M Cluster Buy in Primo Brands

SEC Form 4 filing details showing Eric Foss's insider stock purchase at Primo Brands Corp

Primo Brands Corp (NYSE: PRMB) saw a notable show of insider confidence on August 10, 2026, when Executive Chairman and CEO Eric J. Foss purchased 83,900 shares on the open market at $23.80 per share, a transaction valued at $1,996,543.13. The buy was made with Foss’s own capital rather than through an option exercise or … Read more

COE CEO Huang Buys $3.94M More, Spree Hits $21.5M

Stock chart and SEC filing document representing insider stock purchases by 51Talk Online Education Group CEO

Huang Jack Jiajia, the Chief Executive Officer, a director, and a 10%+ owner of 51Talk Online Education Group (COE), disclosed another open-market purchase of company stock in a Form 4 filing. On August 10, 2026, Huang bought 199,980 shares at $19.72 apiece, a purchase worth $3,943,605.60. Following the transaction, Huang’s indirect holdings — reported as … Read more

RSG: Cascade Investment Buys $108M in Republic Services Stock

Chart showing Republic Services (RSG) stock alongside a series of insider purchase transactions by Cascade Investment

A fresh Form 4 filing shows Cascade Investment, L.L.C., a 10%+ owner of Republic Services, Inc. (NYSE: RSG), purchased 3,200 shares of the waste-management giant on August 11, 2026, at $214.67 per share. The single transaction was worth $686,951.36 and lifted Cascade’s directly held stake to 111,068,846 shares. That trade, however, is just one piece … Read more

BLSM Director Carl Gordon Buys $10M in Open-Market Purchase

SEC Form 4 filing document showing an insider stock purchase disclosure for BlossomHill Therapeutics

A fresh Form 4 filing shows Carl L. Gordon, a director of BlossomHill Therapeutics, Inc. (BLSM), purchased 625,000 shares of the company on the open market on August 10, 2026. The transaction, priced at $16.00 per share, totaled $10,000,000.00 — a purchase made with the insider’s own funds rather than acquired through options or other … Read more

BLSM Insider Buy: OrbiMed Advisors Spends $10M on Shares

Illustration of an SEC Form 4 filing document showing an insider stock purchase by OrbiMed Advisors LLC in BlossomHill Therapeutics

A director of BlossomHill Therapeutics, Inc. (BLSM) put real money on the table this week. According to a Form 4 filing, OrbiMed Advisors LLC purchased 625,000 shares of BlossomHill on August 10, 2026, in an open-market transaction priced at $16.00 per share. The total outlay came to an even $10,000,000.00, funded directly by the insider … Read more

GLIBK: Malone Adds $1.7M in Cluster Buy Topping $13.5M

SEC Form 4 filing showing John C. Malone's insider stock purchase in Liberty Capital Corp/NV (GLIBK)

Liberty Capital Corp/NV (GLIBK) disclosed another insider purchase this week, with director and 10%+ owner John C. Malone buying 66,702 shares on August 12, 2026 at $25.57 per share, a purchase worth $1,705,623.50. Following the transaction, Malone’s directly held stake stands at 2,558,752 shares. The filing is notable less for its standalone size than for … Read more

Kevin Hern Discloses CMCSA Sale Amid Insider Activity

Capitol building alongside a Comcast logo representing a congressional stock disclosure

Rep. Kevin Hern (R-Okla.) has filed a Periodic Transaction Report disclosing a sale of Comcast Corporation Class A Common Stock (CMCSA), made through a jointly-held account with his spouse. The transaction, dated August 5, 2026, falls in the disclosed range of $1,001 to $15,000, according to the filing submitted to the U.S. House of Representatives … Read more

Josh Gottheimer Discloses Crown Castle (CCI) Stock Sale

Illustration of a Capitol building alongside a stock ticker showing CCI trading data

Rep. Josh Gottheimer (D-NJ) has filed a Periodic Transaction Report disclosing a sale of Crown Castle Inc. Common Stock (CCI), according to records submitted to the U.S. House of Representatives under the STOCK Act. The transaction is dated July 23, 2026, and falls in the disclosed range of $1,001 to $15,000. The report lists the … Read more

Gottheimer Discloses Joint Purchase of CrowdStrike (CRWD) Stock

Screenshot-style graphic showing a STOCK Act disclosure for Rep. Josh Gottheimer's CrowdStrike (CRWD) stock purchase

Rep. Josh Gottheimer (D-NJ) has disclosed a new stock purchase under the STOCK Act, reporting a jointly-held transaction in CrowdStrike Holdings, Inc. Class A Common Stock (CRWD) dated July 15, 2026. The Periodic Transaction Report lists the trade as a purchase made through an account held jointly with his spouse, valued in the disclosed range … Read more

Rep. John McGuire’s Spouse Sells PANW Amid Insider Selling

Illustration of a stock disclosure document with the Palo Alto Networks PANW ticker and a congressional seal

A new Periodic Transaction Report filed under the STOCK Act shows that the spouse of Hon. John J Mr McGuire, a member of the U.S. House of Representatives, sold shares of Palo Alto Networks, Inc. (PANW) on July 31, 2026. The transaction, held through a Merrill Lynch SEP IRA, falls in the disclosed range of … Read more

McClain Delaney Child Buys MLM Stock Amid Insider Sale

Stock disclosure document showing MLM transaction details alongside a chart of Martin Marietta Materials shares

A new Periodic Transaction Report filed with the U.S. House of Representatives shows that a dependent child of Hon. April McClain Delaney purchased shares of Martin Marietta Materials, Inc. (MLM) common stock on July 20, 2026. The transaction, disclosed under the STOCK Act, falls within the $1,001 to $15,000 range, the lowest reporting bracket used … Read more

McClain Delaney’s Child Buys MLM Stock as Insider Sells

Screenshot-style graphic showing a STOCK Act disclosure for Martin Marietta Materials (MLM) stock purchase by a congressional dependent

A newly filed Periodic Transaction Report shows that a dependent child of Hon. April McClain Delaney, a member of the U.S. House of Representatives, purchased shares of Martin Marietta Materials, Inc. (MLM) common stock on July 24, 2026. The disclosure, submitted under the STOCK Act, lists the transaction value in the $15,001 to $50,000 range. … Read more